The development and characterization of an E. coli O25B bioconjugate vaccine.
Kowarik M, Wetter M, Haeuptle MA, Braun M, Steffen M, Kemmler S, Ravenscroft N, De Benedetto G, Zuppiger M, Sirena D, Cescutti P, Wacker M.
Kowarik M, et al. Among authors: ravenscroft n.
Glycoconj J. 2021 Aug;38(4):421-435. doi: 10.1007/s10719-021-09985-9. Epub 2021 Mar 17.
Glycoconj J. 2021.
PMID: 33730261
Free PMC article.